BAHEAL Pharmaceutical, a high-end manufacturer of generics in China, of the BAHEAL Pharmaceutical Group, has five generics projects available that have been granted the support for initiation of special projects on the innovation and manufacturing of major new drugs under the 13th Five-year Plan of the state and has become one of the globalized generics producers in China, which also implies that BAHEAL Pharmaceutical has become a leading player across the industry in terms of the capacity in innovation and manufacturing of high-end generics and that the pharmaceutical accompanies in China are also embracing a new epoch that focuses on technology as a core competitiveness.
May 5 witnessed the founding of the Chinese Intelligent Medicine Association of Chinese Medical Doctors Association (CMDA) in Beijing, with presence of LIU Wenxian, Deputy Director-general of the Planning and Information Department under National Health Commission of China; President ZHANG Yanling of Chinese Medical Doctors Association; YOU Zheng, Vice President and member of the Standing CPC Committee at Tsinghua University; Professor Lawrence, Vice President of Duke University in the United States; DONG Jiahong, an academician with the Chinese Academy of Engineering; and BPG Chairman FU Gang, among others.
The award ceremony of “2017 Qingdao Annual Economic Accomplishment Award”, jointly organized by Qingdao Federation of Enterprises, Qingdao Association of Entrepreneurs, Qingdao Publishing Group, and Qingdao Radio and TV Station, was held in the 800 m2 broadcasting studio of Qingdao Radio and TV Station on May 5, 2018. With its excellent contribution and influence in the medical industry, BPG stood out of around 100 competing companies and became winner of the “2017 the Most Influential Company Accomplishment Award” in Qingdao.